Skip to content

AtriCure, Inc.

ATRC

CIK 0001323885

← back to feed
Revenue (TTM)
$535.28M
+14.9% YoY Q1 May 2026
Net Income (TTM)
−$13.1M
+74.4% YoY Q1 May 2026
EPS Diluted (TTM)
−$0.28
+74.7% YoY Q1 May 2026
Gross Margin
75.6%
Q1 May 2026
Operating Margin
-2.1%
Q1 May 2026
Net Margin
-2.4%
Q1 May 2026
Free Cash Flow (TTM)
−$51.43M
Q1 May 2026
Cash
$146.17M
Q1 May 2026
Total Debt
$67.67M
Q1 May 2026
Shares Outstanding
50.64M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings